Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
590,231,680
-
Total 13F shares
-
87,881,992
-
Share change
-
+2,782,550
-
Total reported value
-
$12,493,621,323
-
Put/Call ratio
-
27%
-
Price per share
-
$142.17
-
Number of holders
-
560
-
Value change
-
+$395,158,469
-
Number of buys
-
258
-
Number of sells
-
254
Institutional Holders of Edwards Lifesciences Corp - Common Stock (EW) as of Q3 2015
As of 30 Sep 2015,
Edwards Lifesciences Corp - Common Stock (EW) was held by
560 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
87,881,992 shares.
The largest 10 holders included
VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, Capital Research Global Investors, BlackRock Institutional Trust Company, N.A., FMR LLC, CITADEL ADVISORS LLC, AQR CAPITAL MANAGEMENT LLC, Winslow Capital Management, LLC, BlackRock Fund Advisors, and Voya Investment Management LLC.
This page lists
561
institutional shareholders reporting positions in this security
for the Q3 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.